Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P GIRAUD

Showing results (271-280 of 290) with videos related to

Pageof 29
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 16, 2024
Radiotherapy in the management of lung oligometastasesV Bourbonne, A Lévy, J Khalifa, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 7, 2013
[Tolerance and efficacy of preoperative radiation therapy for elderly patients treated for rectal cancer]E Le Fur, G Chatellier, A Berger, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 15, 2023
[Interprofessional recommendations on behalf of Société française de radiothérapie oncologique for the prevention, protection and management of cyberattacks in radiation oncology]P Giraud, B Fleury, C Le Prince, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 13, 2023
Radiotherapy in the management of synchronous metastatic lung cancerJ Khalifa, A Lévy, L-M Sauvage, et al.
Revue Des Maladies Respiratoires|February 1, 2011
[A phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non squamous, non-small cell lung cancer (NSCLC)]J Tredaniel, F Mornex, I Barillot, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 11, 2020
[Role of immunotherapy in locally advanced non-small cell lung cancer]A Levy, J Doyen, A Botticella, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2020
Chemoradiotherapy efficacy is predicted by intra-tumour CD8+/FoxP3+ double positive T cell density in locally advanced N2 non-small-cell lung carcinomaG Boulle, Y Velut, A Mansuet-Lupo, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 10, 2013
Delegation of medical tasks in French radiation oncology departments: current situation and impact on residents' trainingS Thureau, T Challand, J-E Bibault, et al.
Revue Neurologique|October 15, 2024
Migraine treatment: Position paper of the French Headache SocietyX Moisset, G Demarquay, S de Gaalon, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 23, 2012
[Dosimetric and clinical benefits of respiratory-gated radiotherapy for lung and breast cancers: results of the STIC 2003]P Giraud, J Djadi-Prat, E Morvan, et al.
Pageof 29

Showing results (271-280 of 290) with videos related to

Sort By:
Pageof 29
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 16, 2024
Radiotherapy in the management of lung oligometastasesV Bourbonne, A Lévy, J Khalifa, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 7, 2013
[Tolerance and efficacy of preoperative radiation therapy for elderly patients treated for rectal cancer]E Le Fur, G Chatellier, A Berger, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 15, 2023
[Interprofessional recommendations on behalf of Société française de radiothérapie oncologique for the prevention, protection and management of cyberattacks in radiation oncology]P Giraud, B Fleury, C Le Prince, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 13, 2023
Radiotherapy in the management of synchronous metastatic lung cancerJ Khalifa, A Lévy, L-M Sauvage, et al.
Revue Des Maladies Respiratoires|February 1, 2011
[A phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non squamous, non-small cell lung cancer (NSCLC)]J Tredaniel, F Mornex, I Barillot, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 11, 2020
[Role of immunotherapy in locally advanced non-small cell lung cancer]A Levy, J Doyen, A Botticella, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2020
Chemoradiotherapy efficacy is predicted by intra-tumour CD8+/FoxP3+ double positive T cell density in locally advanced N2 non-small-cell lung carcinomaG Boulle, Y Velut, A Mansuet-Lupo, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 10, 2013
Delegation of medical tasks in French radiation oncology departments: current situation and impact on residents' trainingS Thureau, T Challand, J-E Bibault, et al.
Revue Neurologique|October 15, 2024
Migraine treatment: Position paper of the French Headache SocietyX Moisset, G Demarquay, S de Gaalon, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 23, 2012
[Dosimetric and clinical benefits of respiratory-gated radiotherapy for lung and breast cancers: results of the STIC 2003]P Giraud, J Djadi-Prat, E Morvan, et al.
Pageof 29